Concepts (122)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| CD8-Positive T-Lymphocytes | 5 | 2020 | 115 | 1.220 |
Why?
|
| Astrocytes | 5 | 2020 | 150 | 1.200 |
Why?
|
| HIV-1 | 6 | 2020 | 242 | 0.820 |
Why?
|
| HIV Infections | 5 | 2020 | 488 | 0.750 |
Why?
|
| AIDS Dementia Complex | 2 | 2017 | 40 | 0.590 |
Why?
|
| Leukocytes, Mononuclear | 2 | 2015 | 56 | 0.580 |
Why?
|
| Wnt Proteins | 2 | 2014 | 22 | 0.560 |
Why?
|
| Theilovirus | 3 | 2012 | 3 | 0.550 |
Why?
|
| CD4 Antigens | 1 | 2015 | 30 | 0.500 |
Why?
|
| Wnt Signaling Pathway | 1 | 2015 | 33 | 0.480 |
Why?
|
| beta Catenin | 5 | 2017 | 65 | 0.460 |
Why?
|
| Demyelinating Diseases | 2 | 2011 | 15 | 0.450 |
Why?
|
| Disease Models, Animal | 5 | 2017 | 619 | 0.440 |
Why?
|
| Multiple Sclerosis | 2 | 2012 | 107 | 0.410 |
Why?
|
| Membrane Proteins | 1 | 2014 | 167 | 0.410 |
Why?
|
| Mice | 9 | 2020 | 1445 | 0.370 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 2011 | 35 | 0.350 |
Why?
|
| Cells, Cultured | 3 | 2015 | 538 | 0.320 |
Why?
|
| Animals | 9 | 2020 | 3750 | 0.290 |
Why?
|
| Brain | 1 | 2015 | 1662 | 0.260 |
Why?
|
| Mice, SCID | 4 | 2020 | 45 | 0.230 |
Why?
|
| Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 2 | 2014 | 15 | 0.200 |
Why?
|
| Signal Transduction | 3 | 2017 | 447 | 0.200 |
Why?
|
| Mice, Inbred NOD | 3 | 2020 | 29 | 0.200 |
Why?
|
| Transcription Factors | 2 | 2014 | 170 | 0.190 |
Why?
|
| Mice, Knockout | 3 | 2020 | 316 | 0.180 |
Why?
|
| Cardiovirus Infections | 2 | 2011 | 2 | 0.180 |
Why?
|
| Receptors, IgG | 1 | 2020 | 12 | 0.180 |
Why?
|
| T-Lymphocyte Subsets | 1 | 2020 | 41 | 0.170 |
Why?
|
| Virus Release | 1 | 2020 | 6 | 0.170 |
Why?
|
| Blood-Brain Barrier | 1 | 2020 | 39 | 0.170 |
Why?
|
| Hippocampus | 1 | 2020 | 278 | 0.150 |
Why?
|
| Methamphetamine | 1 | 2017 | 23 | 0.140 |
Why?
|
| Central Nervous System Stimulants | 1 | 2017 | 41 | 0.140 |
Why?
|
| Flow Cytometry | 2 | 2020 | 116 | 0.130 |
Why?
|
| Lysosomal-Associated Membrane Protein 1 | 1 | 2015 | 3 | 0.130 |
Why?
|
| Lysosomal-Associated Membrane Protein 2 | 1 | 2015 | 3 | 0.130 |
Why?
|
| Interleukin Receptor Common gamma Subunit | 1 | 2015 | 5 | 0.130 |
Why?
|
| Heterografts | 1 | 2015 | 15 | 0.130 |
Why?
|
| CD8 Antigens | 1 | 2015 | 11 | 0.130 |
Why?
|
| Substance-Related Disorders | 1 | 2017 | 98 | 0.130 |
Why?
|
| Spleen | 1 | 2015 | 34 | 0.130 |
Why?
|
| Cell Movement | 1 | 2015 | 84 | 0.120 |
Why?
|
| Lymphocyte Activation | 1 | 2015 | 86 | 0.120 |
Why?
|
| Claudins | 1 | 2015 | 6 | 0.120 |
Why?
|
| Humans | 10 | 2020 | 28181 | 0.120 |
Why?
|
| HLA-DR Antigens | 1 | 2014 | 11 | 0.120 |
Why?
|
| Culture Media, Conditioned | 1 | 2014 | 18 | 0.120 |
Why?
|
| STAT3 Transcription Factor | 1 | 2014 | 15 | 0.120 |
Why?
|
| HIV | 1 | 2014 | 42 | 0.110 |
Why?
|
| Neurons | 1 | 2017 | 343 | 0.110 |
Why?
|
| Interferon-gamma | 1 | 2014 | 83 | 0.110 |
Why?
|
| Acyltransferases | 1 | 2014 | 4 | 0.110 |
Why?
|
| Leukocytes | 1 | 2014 | 37 | 0.110 |
Why?
|
| Cell Proliferation | 2 | 2014 | 178 | 0.110 |
Why?
|
| Fetus | 1 | 2014 | 38 | 0.110 |
Why?
|
| Gastrointestinal Neoplasms | 1 | 2014 | 25 | 0.110 |
Why?
|
| Colon | 1 | 2015 | 137 | 0.110 |
Why?
|
| Stem Cells | 1 | 2014 | 40 | 0.110 |
Why?
|
| Virus Replication | 1 | 2014 | 52 | 0.110 |
Why?
|
| Monocytes | 1 | 2014 | 65 | 0.110 |
Why?
|
| Macrophages | 1 | 2014 | 108 | 0.100 |
Why?
|
| Mice, Inbred C57BL | 2 | 2012 | 438 | 0.100 |
Why?
|
| Immunologic Techniques | 1 | 2012 | 3 | 0.100 |
Why?
|
| Fas Ligand Protein | 1 | 2011 | 6 | 0.100 |
Why?
|
| Haplotypes | 1 | 2011 | 60 | 0.090 |
Why?
|
| Promoter Regions, Genetic | 1 | 2011 | 95 | 0.090 |
Why?
|
| Glucocorticoid-Induced TNFR-Related Protein | 1 | 2011 | 1 | 0.090 |
Why?
|
| Receptors, Nerve Growth Factor | 1 | 2011 | 9 | 0.090 |
Why?
|
| Mice, Inbred Strains | 1 | 2011 | 31 | 0.090 |
Why?
|
| Receptors, Tumor Necrosis Factor | 1 | 2011 | 27 | 0.090 |
Why?
|
| Interleukin-2 Receptor alpha Subunit | 1 | 2011 | 13 | 0.090 |
Why?
|
| Forkhead Transcription Factors | 1 | 2011 | 23 | 0.090 |
Why?
|
| Cell Line, Tumor | 3 | 2020 | 253 | 0.090 |
Why?
|
| Encephalomyelitis, Autoimmune, Experimental | 1 | 2012 | 67 | 0.090 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2011 | 97 | 0.090 |
Why?
|
| Central Nervous System | 1 | 2011 | 60 | 0.090 |
Why?
|
| Mice, Transgenic | 1 | 2011 | 224 | 0.090 |
Why?
|
| T-Lymphocytes, Cytotoxic | 1 | 2010 | 24 | 0.080 |
Why?
|
| Antibodies, Monoclonal | 1 | 2011 | 199 | 0.080 |
Why?
|
| Adoptive Transfer | 3 | 2014 | 32 | 0.070 |
Why?
|
| Anti-Retroviral Agents | 2 | 2020 | 19 | 0.070 |
Why?
|
| Severity of Illness Index | 1 | 2011 | 978 | 0.070 |
Why?
|
| CD4-Positive T-Lymphocytes | 2 | 2020 | 116 | 0.070 |
Why?
|
| Viral Load | 2 | 2020 | 75 | 0.060 |
Why?
|
| Transcription Factor 4 | 2 | 2014 | 8 | 0.050 |
Why?
|
| Molecular Sequence Data | 2 | 2012 | 195 | 0.050 |
Why?
|
| Cell Separation | 1 | 2020 | 29 | 0.040 |
Why?
|
| CD4 Lymphocyte Count | 1 | 2020 | 55 | 0.040 |
Why?
|
| Anti-HIV Agents | 1 | 2020 | 69 | 0.040 |
Why?
|
| Male | 2 | 2017 | 15232 | 0.040 |
Why?
|
| Animals, Genetically Modified | 1 | 2017 | 18 | 0.040 |
Why?
|
| Cellular Senescence | 1 | 2017 | 18 | 0.040 |
Why?
|
| Primary Cell Culture | 1 | 2017 | 28 | 0.040 |
Why?
|
| Calcium-Binding Proteins | 1 | 2017 | 22 | 0.040 |
Why?
|
| Microfilament Proteins | 1 | 2017 | 24 | 0.040 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2017 | 29 | 0.030 |
Why?
|
| Rats | 1 | 2017 | 674 | 0.030 |
Why?
|
| Gene Expression Regulation | 1 | 2017 | 281 | 0.030 |
Why?
|
| DNA-Binding Proteins | 1 | 2017 | 275 | 0.030 |
Why?
|
| Microscopy, Fluorescence | 1 | 2015 | 78 | 0.030 |
Why?
|
| Leukocyte Transfusion | 1 | 2014 | 4 | 0.030 |
Why?
|
| Receptors, Interleukin-2 | 1 | 2014 | 7 | 0.030 |
Why?
|
| Neoplasms, Experimental | 1 | 2014 | 10 | 0.030 |
Why?
|
| HCT116 Cells | 1 | 2014 | 11 | 0.030 |
Why?
|
| Carcinogenesis | 1 | 2014 | 24 | 0.030 |
Why?
|
| Female | 1 | 2011 | 15692 | 0.030 |
Why?
|
| Lymphoid Enhancer-Binding Factor 1 | 1 | 2011 | 2 | 0.020 |
Why?
|
| Vaccination | 1 | 2012 | 32 | 0.020 |
Why?
|
| Amino Acid Sequence | 1 | 2012 | 157 | 0.020 |
Why?
|
| Gene Knockdown Techniques | 1 | 2011 | 45 | 0.020 |
Why?
|
| Binding Sites | 1 | 2011 | 75 | 0.020 |
Why?
|
| Base Sequence | 1 | 2011 | 108 | 0.020 |
Why?
|
| Protein Binding | 1 | 2011 | 129 | 0.020 |
Why?
|
| T-Lymphocytes | 1 | 2011 | 98 | 0.020 |
Why?
|
| Colonic Neoplasms | 1 | 2011 | 64 | 0.020 |
Why?
|
| Peptides | 1 | 2012 | 103 | 0.020 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2011 | 114 | 0.020 |
Why?
|
| Up-Regulation | 1 | 2011 | 179 | 0.020 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2011 | 285 | 0.020 |
Why?
|
| Epitopes, T-Lymphocyte | 1 | 2010 | 15 | 0.020 |
Why?
|
| Disease Progression | 1 | 2012 | 707 | 0.020 |
Why?
|